Annual Conference of the Canadian Blood and Marrow Transplant Group. June 11 to 14, 2014 The Westin Nova Scotian 1181 Hollis Street Halifax, NS

Transcription

1 Annual Conference of the Canadian Blood Preliminary Program In conjunction with the Canadian National, Canadian Apheresis Group, Society, and Vector CBMTG Head Office Malachite Management Inc 375 West 5th Avenue Suite 201, Vancouver BC Canada V5Y 1J6 T F Web:

2 Canadian Blood (CBMTG) The Canadian Blood is a national, voluntary, and multi-disciplinary organization providing leadership and promoting excellence in patient care, research, and education in the field of blood and marrow transplant (BMT). CBMTG believes that every patient has a right to the highest standards of care that can be provided by blood and marrow transplant professionals in Canada. Our vision is that Canada will be the best place in the world to have a blood and marrow transplant. Our mission is to be the voice of experts working in the field of blood and marrow transplant. The organization leads education and research across the Canadian BMT field. CBMTG holds an annual conference, organizes free webinars for its members, has a robust clinical trials program and has led the development of the national BMT registry. The Conference Planning Committee, led by Dr. Stephen Couban, has created a scientific program highlighting presentations on topics of interest in the field of BMT. This program was designed for a multidisciplinary audience and topics were chosen with care. CBMTG sessions will be organized from Thursday, June 12 to Saturday June 14, Canadian National (CNTRP) The Canadian National is a national initiative designed to increase organ and tissue donation in Canada and enhance the survival and quality of life of Canadians who receive transplants. The program is based out of Alberta Transplant Institute at the University of Alberta in Edmonton and brings together 105 investigators and 86 collaborators from across Canada to carry out research and develop resources to help Canadians waiting for a tissue or organ transplant. The Society will host sessions Tuesday, June 10, 2014 to Thursday, June 12, Canadian Apheresis Group (CAG) The Canadian Apheresis Group was formed in The group includes representatives from approximately 40 apheresis units in 19 major medical centers in Canada. At the annual meeting of the CAG we focus on new evidence and techniques for plasma exchange, and also carry out a centre-bycentre review. The society will host sessions Friday, June 13, 2014 to Sunday, June 15, Society (CHS) The Society represents all physicians and scientists with an interest in the discipline in Canada. At present there are over 280 members. The Society will host a combined session with the CBMTG on Friday, June 13, 2014 from 9:00 am 12:00 pm Venous Thrombosis Clinical Trials Organisation (VECTOR) VECTOR is a collaborative group of thrombosis physicians from various cities in Canada (Ottawa, Montreal. Halifax, Hamilton, Saskatoon, London) who discuss current and new research ideas in the area of thrombosis. The VECTOR members are expected to help the progress of multi-centre academic projects awarded to individual group members. The executive meets via teleconference on a monthly basis to discuss the group s operations and face-to-face up to four times a years (rotating facility hosting the meetings). The Society will host a combined session with the CBMTG on Friday, June 13, 2014 from 9:00 am 12:00 pm CBMTG Head Office Malachite Management Inc 375 West 5th Avenue Suite 201, Vancouver BC Canada V5Y 1J6 T F cbmtg@malachite-mgmt.com Web:

3 Preliminary Program Day One: Wednesday, June 11, 2014 Session 1: Canadian National (CNTRP) Session (details forthcoming) Day Two: Thursday, June 12, :00am 11:00am 11:00am 1:00pm 1:00pm 4:00pm 4:00pm 4:15pm 4:15pm 6:15pm 6:15pm 7:30pm 7:30pm 9:30pm Session 2: Joint CBMTG and CNTRP Session Topics: Immunity and infections post-transplant PTLD Symposium #1: Lunch Session 3A: Clinical Trials Network Meeting Chair: Donna Wall, MD Session 3B: Nurse Practitioners, Pharmacists, and BMT Coordinators Meeting Chairs: Jo-Ann Edwards, NP, Gertrude Kells, RN Session 3C: BMT Laboratory Technologists Chairs: Angeline Giftakis, MLT, Marie Tulloch, MLT, Giovanna Cameron Session 4: CBMTG National Registry Meeting Chair: Kristjan Paulson, MD Welcome Reception Dinner for Laboratory Technologists Chair: Angeline Giftakis, MLT Day Three: Friday, June 13, :30am 8:45am 9:00am 12:00pm 12:00pm 2:00pm Symposium #2: Breakfast Session 5: CBMTG Joint Session with Society, Vector Chairs: Stephen Couban, MD and Joanne Hickey, MD, FRCPC 9:00am 10:00am 10:00am 11:00am 11:00am 12:00pm Symposium #3: Lunch Diagnosis and treatment of aplastic anemia Speaker: Neal Young, MD Thrombosis and malignant hematology: Lines, platelets, bleeding Speakers: Sudeep Shivakumar, MD, FRCPC and Marc Carrier, MD, MSc, FRCPC Overview of PNH Speaker: TBD 3

4 Day Three: Friday, June 13, 2014 Session 6A: Chairs: Gizelle Popradi, MD and Jo-Ann Edwards, NP 2:00pm 3:30pm 3:30pm 4:00pm 4:00pm 6:00pm 6:00pm 7:00pm 7:30pm onward 2:00pm 2:45pm Age and transplant Speaker: Andrew Artz, MD, MS 2:00pm 4:00pm 2:45pm 3:30pm Case-based presentation related to compliance, fertility and comorbidities Speaker: TBD Session 6B: CAG Nursing Session Session 7: Chairs: Andrea Kew, MD and Marie Tulloch, MLT Choosing the best donor Speakers: Mindy Goldman, MD, FRCPC, John Miller, MD, Wing Leung, MD, PhD CBMTG Annual General Meeting Symposium #4: Dinner Day Four: Saturday, June 14, :30am 8:45am Symposium #5: Breakfast Session 8A: Adult Session: Clinical Chairs: Imran Ahmad, MD and John Kuruvilla, MD 9:00am 12:00pm 12:00pm 2:00pm 2:00pm 3:00pm Autologous transplant for aggressive histology lymphoma (primary refractory, relapsed and transformed) Speakers: Craig Moskowitz, MD, Michael Crump, MD Myeloma: Maintenance therapy Speaker: TBD Session 8B: Pediatric Session Chairs: Conrad Fernandez, MD, FRCPC and David Mitchell, MD, FRCPC Metabolic disorders in the age of expanding newborn programs Speaker: Joanne Kurtzberg, MD Kir typing Speaker: Wing Leung, MD, PhD Transplant decision making for MRD+ve ALL Speaker: Peter Bader, MD Symposium #6: Lunch Session 9: Messner Lecture Chairs: Raewyn Broady, MD and Wanda Hasegawa, MD Allogeneic transplant for refractory AML Speaker: Richard Larson, MD Session 8C: CAG Educational Session 4

5 Day Four: Saturday, June 14, :00pm 3:15pm 3:15pm 4:15pm 4:15pm 5:15pm Session 10: Abstract presentations Session 11: Saunders Lecture: Debate Chairs: Lynn Savoie, MD and Kylie Lepic, MD Be it resolved that patients with acute lymphoblastic leukemia should have an allogeneic transplant in CR1 Session 8C: CAG Educational Session 5:15pm 7:00pm Onwards For the resolution: Daniel Weisdorf, MD Against the resolution: Matthew Seftel, MD Closing Remarks Evening Social Day 5: Sunday, January 15, :00am 9:00pm Symposium #7: Breakfast 9:00am 12:00pm Session 12: CAG Session To register for the conference please go to or click here. 5